Eligibility Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module

Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2025-12-25 @ 1:40 AM
NCT ID: NCT07162194
Eligibility Criteria: Inclusion Criteria: * PROSTATE BIOPSY COHORT: Patients undergoing transperineal MRI/TRUS fusion prostate biopsy (PBx) as per standard of care * PROSTATE BIOPSY COHORT: Patients who underwent or are undergoing 3T multiparametric MRI (T2W, diffusion weighted imaging \[DWI\], apparent diffusion coefficient \[ADC\], and dynamic contrast-enhanced \[DCE\]) within 90 days prior to biopsy * PROSTATE BIOPSY COHORT: Patients who provided with consent for the study * RADICAL PROSTATECTOMY COHORT: Patients undergoing radical prostatectomy without neo-adjuvant hormonal therapy for primary treatment of prostate cancer as per standard of care * RADICAL PROSTATECTOMY COHORT: Patients who underwent or are undergoing 3T multiparametric MRI (T2W, DWI, ADC, and DCE) within 180 days prior to radical prostatectomy * RADICAL PROSTATECTOMY COHORT: Patients who provided with consent for the study Exclusion Criteria: * PROSTATE BIOPSY COHORT: Patients with a history of prostate cancer * PROSTATE BIOPSY COHORT: Patients with a history of surgical treatment on benign prostate hyperplasia * PROSTATE BIOPSY COHORT: Patients undergoing saturation prostate biopsy * PROSTATE BIOPSY COHORT: Patients under 20 years old * PROSTATE BIOPSY COHORT: Patients with previous PBx history * PROSTATE BIOPSY COHORT: MRI which was not interpreted by PIRADS * PROSTATE BIOPSY COHORT: MRI with significant artifact * RADICAL PROSTATECTOMY COHORT: Patients with a history of surgical treatment on benign prostate hyperplasia * RADICAL PROSTATECTOMY COHORT: Patients under 20 years old * RADICAL PROSTATECTOMY COHORT: Patients without pre-treatment MRI * RADICAL PROSTATECTOMY COHORT: MRI which was not interpreted by PIRADS * RADICAL PROSTATECTOMY COHORT: MRI with significant artifact
Healthy Volunteers: False
Sex: MALE
Minimum Age: 20 Years
Study: NCT07162194
Study Brief:
Protocol Section: NCT07162194